Medscape1d
Despite Price Caps, Some Still Struggle to Access Insulin
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Endocrinology Advisor1d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
Business Insider4y
Yes, insulin does expire — here's how long it takes and when you should no longer use it
Once you open a vial of insulin or pen, another expiration date starts. Generally, insulin expires 28 days after it's opened (for a vial or pen), says Fernandez de Fiore, but some pens only last 7 ...
Medscape1y
Patient Satisfaction and Costs Associated With Insulin Administered by Pen Device or Syringe During Hospitalization
Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.